Oslo, 31 August 2023: In the first half 2023, Thor Medical ASA completed the close down of the PARADIGME study and reduced the burn to prese...
Oslo, 17 August 2023: Thor Medical ASA will release its first half results on Thursday 31 August 2023 at 07:00 am (CEST).
Nordic Nanovector – Completion of annual general meeting
The Chairman will vote for 10.606.127 shares (or 9,14%) and the Interim CEO & CFO will vote for 20.
Nordic Nanovector - Mandatory notification of trade - primary insider
Nordic Nanovector ASA: Results for the First Quarter 2022
Nordic Nanovector ASA: The Annual General Meeting held
Nordic Nanovector ASA: R&D Day to be virtual via live webcast only
Nordic Nanovector ASA: Invitation to attend R&D Day
Nordic Nanovector ASA: Results for the Third Quarter 2021
Nordic Nanovector ASA: Resultat for tredje kvartal 2021
Abstract by The Health Policy Partnership entitled “System-Level Barriers to Uptake of Existing and Novel Radioimmunotherapy for People with...
Nordic Nanovector ASA: Results for the Second Quarter and First Half 2021
Nordic Nanovector ASA: Resultat for andre kvartal og første halvår 2021
Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2021 Results Presentation Webcast
